Scholar Rock (SRRK)
(Delayed Data from NSDQ)
$10.33 USD
-0.34 (-3.19%)
Updated May 28, 2024 04:00 PM ET
After-Market: $10.31 -0.02 (-0.19%) 7:22 PM ET
4-Sell of 5 4
F Value F Growth D Momentum F VGM
Brokerage Reports
0 items in cart
Scholar Rock Holding Corporation [SRRK]
Reports for Purchase
Showing records 21 - 40 ( 118 total )
Company: Scholar Rock Holding Corporation
Industry: Medical - Biomedical and Genetics
SAPPHIRE Topline Data in 2H24; SRK-181 Data in 2H23; Reit. Buy and $30 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: MALDONADO A
Company: Scholar Rock Holding Corporation
Industry: Medical - Biomedical and Genetics
Company: Scholar Rock Holding Corporation
Industry: Medical - Biomedical and Genetics
KOLs Highlight Apitegromab?s Potential Through Detailed Patient Perspectives
Provider: H.C. Wainwright & Co., Inc.
Analyst: MALDONADO A
Company: Scholar Rock Holding Corporation
Industry: Medical - Biomedical and Genetics
Company: Scholar Rock Holding Corporation
Industry: Medical - Biomedical and Genetics
Scholar Has the Brains, Going After the Brawn
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D
Company: Scholar Rock Holding Corporation
Industry: Medical - Biomedical and Genetics
Company: Scholar Rock Holding Corporation
Industry: Medical - Biomedical and Genetics
Apitegromab Continues to Deliver Benefit at 36 Months, Strengthening Its Potential in SMA
Provider: H.C. Wainwright & Co., Inc.
Analyst: MALDONADO A
Company: Scholar Rock Holding Corporation
Industry: Medical - Biomedical and Genetics
Scholar Graduates to Master, on to Doctorate
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D
Company: Scholar Rock Holding Corporation
Industry: Medical - Biomedical and Genetics
Company: Scholar Rock Holding Corporation
Industry: Medical - Biomedical and Genetics
Company: Scholar Rock Holding Corporation
Industry: Medical - Biomedical and Genetics
ASCO 2023 Abstract Roundup for Covered Companies
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D
Company: Scholar Rock Holding Corporation
Industry: Medical - Biomedical and Genetics
Upcoming Data From Apitegromab and SRK-181, Poised to Continue Pipeline Momentum
Provider: H.C. Wainwright & Co., Inc.
Analyst: MALDONADO A
Company: Scholar Rock Holding Corporation
Industry: Medical - Biomedical and Genetics
At 3 years, will the Scholar graduate to Master?
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D
Company: Scholar Rock Holding Corporation
Industry: Medical - Biomedical and Genetics
Updates Across Pipeline Add to Positive Profiles For Apitegromab and SRK-181; Reit. Buy and $30 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: MALDONADO A
Company: Scholar Rock Holding Corporation
Industry: Medical - Biomedical and Genetics
Company: Scholar Rock Holding Corporation
Industry: Medical - Biomedical and Genetics
Crouching TOPAZ, hidden DRAGON: glimpses of data throughout ?23
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D
Company: Scholar Rock Holding Corporation
Industry: Medical - Biomedical and Genetics
Company: Scholar Rock Holding Corporation
Industry: Medical - Biomedical and Genetics
A TGF Platform That Continues to Deepen; Reit. Buy and $30 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: MALDONADO A
Company: Scholar Rock Holding Corporation
Industry: Medical - Biomedical and Genetics
Company: Scholar Rock Holding Corporation
Industry: Medical - Biomedical and Genetics
SRK-181 Shows New Signals of Positive Momentum During SITC ?22
Provider: H.C. Wainwright & Co., Inc.
Analyst: MALDONADO A